A research identified immunotherapy targets in 12 pediatric cancers, and GPC2 was analyzed in 8 diseases such as osteosarcoma (OS) and Ewing sarcoma (EWS), which makes it evident that GPC2 has a wide range of functions in childhood cancers (20). This evidence concerns the gene GPC2 and childhood malignant neoplasm.